Growth Metrics

Boston Scientific (BSX) Cash from Investing Activities Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -253.01%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -11.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -41.67%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -6.88%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -472.46%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -16.93%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -111.03%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -40.94%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -2.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.88%
Dec 31, 2025 -40.91%
Sep 30, 2025 -30.67%
Jun 30, 2025 -238.62%
Mar 31, 2025 31.77%
Dec 31, 2024 -100.29%
Sep 30, 2024 -5.74%
Mar 31, 2024 -81.85%
Dec 31, 2023 -92.77%
Sep 30, 2023 -15.16%
Jun 30, 2023 -142.37%
Mar 31, 2023 -85.36%
Dec 31, 2022 -55.15%
Sep 30, 2022 61.56%
Jun 30, 2022 63.97%
Mar 31, 2022 -56.58%
Dec 31, 2021 8.15%
Sep 30, 2021 -22.17%
Mar 31, 2021 34.08%
Dec 31, 2020 20.17%
Sep 30, 2020 -8.14%
Jun 30, 2020 50.24%
Mar 31, 2020 18.42%
Dec 31, 2019 54.84%
Sep 30, 2019 -168.36%
Jun 30, 2019 -82.50%
Mar 31, 2019 -104.42%
Dec 31, 2018 -51.83%
Sep 30, 2018 27.25%
Jun 30, 2018 -25.91%
Mar 31, 2018 -50.25%
Dec 31, 2017 -51.57%
Sep 30, 2017 40.03%
Jun 30, 2017 -56.91%
Mar 31, 2017 -29.14%
Dec 31, 2016 -13.59%
Sep 30, 2016 -41.08%
Jun 30, 2016 -53.87%
Mar 31, 2016 -63.41%
Dec 31, 2015 14.61%
Sep 30, 2015 -218.91%
Jun 30, 2015 -9.57%
Mar 31, 2015 8.24%
Dec 31, 2014 -17.63%
Sep 30, 2014 -100.14%
Jun 30, 2014 -14.78%
Mar 31, 2014 -27.39%
Dec 31, 2013 -13.09%
Sep 30, 2013 2.60%
Jun 30, 2013 24.09%
Mar 31, 2013 47.03%
Dec 31, 2012 -65.71%
Sep 30, 2012 17.09%
Jun 30, 2012 -14.99%
Mar 31, 2012 49.65%